Association of monocyte to HDL cholesterol level with contrast induced nephropathy in STEMI patients treated with primary PCI

Sag S., YILDIZ A., Kaderli A. A., Gul B. C., Bedir O., Cegilli E., ...More

CLINICAL CHEMISTRY AND LABORATORY MEDICINE, vol.55, no.1, pp.132-138, 2017 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 55 Issue: 1
  • Publication Date: 2017
  • Doi Number: 10.1515/cclm-2016-0005
  • Journal Name: CLINICAL CHEMISTRY AND LABORATORY MEDICINE
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Page Numbers: pp.132-138
  • Keywords: contrast induced nephropathy, HDL-cholesterol, monocyte, PERCUTANEOUS CORONARY INTERVENTION, ACUTE KIDNEY INJURY, HIGH-DENSITY-LIPOPROTEIN, ELEVATION MYOCARDIAL-INFARCTION, CREATININE CLEARANCE RATIO, PRIMARY ANGIOPLASTY, CARDIOVASCULAR EVENTS, N-ACETYLCYSTEINE, RENAL-FUNCTION, RISK SCORE
  • Bursa Uludag University Affiliated: Yes

Abstract

Background: Contrast induced nephropathy (CIN) has been proven to be a clinical condition related to adverse cardiovascular outcomes. In recent studies, the monocyte to high density lipoprotein ratio (MHR) has been-postulated as a novel parameter associated with adverse renal and cardiovascular outcomes. In this study we-investigated the association of MHR with CIN in-ST-segment elevation myocardial infarction (STEMI) patients treated with primary percutaneous coronary intervention (PCI).